Category: Life Sciences
United States Life Sciences
-
Blood Transfusion Diagnostics
... at a CAGR of 4.7% over the analysis period 2024-2030. Blood Transfusion Diagnostic Instruments, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.7 Billion by the ... Read More
-
Endometrial Ablation Devices
... at a CAGR of 5.6% over the analysis period 2024-2030. Radiofrequency Ablation, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$628.5 Million by the end of ... Read More
-
Nail Care
... CAGR of 2.6% over the analysis period 2024-2030. Nail Polishes, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$8.3 Billion by the end of the analysis ... Read More
-
Fibrin Sealants
... CAGR of 6.1% over the analysis period 2024-2030. Fibrin Sealant Liquid, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$1.2 Billion by the end of the ... Read More
-
Office Administrative Services
... at a CAGR of 7.9% over the analysis period 2024-2030. Administrative Management Services, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$62.1 Billion by the end ... Read More
-
Whole Exome Sequencing
... at a CAGR of 20.2% over the analysis period 2024-2030. Whole Exome Sequencing Systems, one of the segments analyzed in the report, is expected to record a 21.3% CAGR and reach US$4.1 Billion by the ... Read More
-
Intrauterine Devices
... CAGR of 3.8% over the analysis period 2024-2030. Hormonal Progestogen-Releasing IUD, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$3.4 Billion by the end of the ... Read More
-
Library Furniture
... CAGR of 8.7% over the analysis period 2024-2030. Tables, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$3.9 Billion by the end of the analysis period. ... Read More
-
Long-Term Care
... CAGR of 5.5% over the analysis period 2024-2030. Public Payer, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.1 Trillion by the end of the analysis ... Read More
-
Pyrogen Testing
... CAGR of 10.4% over the analysis period 2024-2030. Pyrogen Testing Assays, Kits & Reagents, one of the segments analyzed in the report, is expected to record a 10.9% CAGR and reach US$1.1 Billion by the ... Read More
-
Sleeping Aids
... CAGR of 5.3% over the analysis period 2024-2030. Sleep Apnea Devices, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$36.9 Billion by the end of the ... Read More
-
Produce Packaging Trays
... at a CAGR of 4.1% over the analysis period 2024-2030. Growers / Shippers End-Use, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.0 Billion by the ... Read More
-
Analytical Laboratory Services
... at a CAGR of 9.0% over the analysis period 2024-2030. Bioanalytical Testing Services, one of the segments analyzed in the report, is expected to record a 9.5% CAGR and reach US$273.4 Million by the end ... Read More
-
Clot Management Devices
... at a CAGR of 4.6% over the analysis period 2024-2030. Percutaneous Thrombectomy Devices, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$1.1 Billion by the end ... Read More
-
Genotyping
... 15.3% over the analysis period 2024-2030. Polymerase Chain Reaction (PCR) Technology, one of the segments analyzed in the report, is expected to record a 15.9% CAGR and reach US$10.9 Billion by the end of the ... Read More
-
Herpes Marker Testing
... at a CAGR of 4.9% over the analysis period 2024-2030. Antibody / Antigen-Based Kits, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$332.9 Million by the ... Read More
-
Photography Equipment
... CAGR of -9.2% over the analysis period 2024-2030. Cameras, one of the segments analyzed in the report, is expected to record a -10.4% CAGR and reach US$2.1 Billion by the end of the analysis period. ... Read More
-
Polyphenols
... 7.2% over the analysis period 2024-2030. Functional Beverages Application, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$855.9 Million by the end of the analysis period. ... Read More
-
In-Vitro Fertilization
... CAGR of 8.0% over the analysis period 2024-2030. In-Vitro Fertilization Equipment, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$684.2 Million by the end of the ... Read More
-
Microgrid as a Service (MaaS)
... Billion by 2030, growing at a CAGR of 15.7% over the analysis period 2024-2030. Grid Connected MaaS, one of the segments analyzed in the report, is expected to record a 13.6% CAGR and reach US$4.2 ... Read More
-
Gluten Free Products
... at a CAGR of 5.9% over the analysis period 2024-2030. Gluten Free Bakery Products, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$4.7 Billion by the ... Read More
-
Radiopharmaceuticals
... 11.0% over the analysis period 2024-2030. SPECT Radioisotopes, one of the segments analyzed in the report, is expected to record a 10.4% CAGR and reach US$6.2 Billion by the end of the analysis period. Growth ... Read More
-
Soldier Systems
... CAGR of 4.8% over the analysis period 2024-2030. Personal Protection Application, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$3.8 Billion by the end of the ... Read More
-
OTT Devices and Services
... 2030, growing at a CAGR of 17.9% over the analysis period 2024-2030. Video Content, one of the segments analyzed in the report, is expected to record a 18.3% CAGR and reach US$252.9 Billion by the ... Read More
-
COVID-19 Testing
... CAGR of -15.7% over the analysis period 2024-2030. RT-PCR Assay Kits, one of the segments analyzed in the report, is expected to record a -16.5% CAGR and reach US$3.9 Billion by the end of the ... Read More
Research Assistance
